Samuel Baklache - Gefen Biomed Insider

GEFEN -- Israel Stock  

null 4.80  0.00  0.00%

External Director

We currently do not have informatin regarding Samuel Baklache. This executive tanure with Gefen Biomed Investments Ltd is not currenlty determined.
Age: 51  Director Since 2008      
972 8 675 1122

Management Efficiency

The company has return on total asset (ROA) of 20.33 % which means that it generated profit of $20.33 on every $100 spent on asset. This is normal as compared to the sector avarege.
The company has accumulated 20.23 M in total debt with debt to equity ratio (D/E) of 0.49 which is about average as compared to similar companies. Gefen Biomed Investments Ltd has Current Ratio of 0.58 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

Similar Executives

Showing few of many executives


Joav NachshonMizrahi Tefahot Bank Ltd
Eldad MosheBezeq The Israel Telecommunicat
Yoram BenZeevElbit Systems Ltd
Tamar GottliebBank Leumi le Israel B M
Shlomo RodavBezeq The Israel Telecommunicat
David AvnerBank Leumi le Israel B M
Moshe DovratBank Leumi le Israel B M
Maya FarberFrutarom Industries Ltd
Joseph ShachakMizrahi Tefahot Bank Ltd
Sandra FarberFrutarom Industries Ltd
Gary CohenPerrigo Company plc
Avraham AsheriElbit Systems Ltd
Zehava SimonNICE Ltd
Yehoshua EhrlichNICE Ltd
Oran DrorAzrieli Group Ltd
Efraim SadkaBank Leumi le Israel B M
HajYehia SamerBank Leumi le Israel B M
Arieh GansBank Leumi le Israel B M
Orna YosefOil Refineries Ltd
Bradley AlfordPerrigo Company plc
Joseph CowanNICE Ltd

Entity Summary

Gefen Biomed Investments Ltd engages in the location, screening, and investment in earlystage medical devices and biotechnology companies. Gefen Biomed Investments Ltd (GEFEN) is traded on Tel Aviv Stock Exchange in Israel. It is located in Ashkelon, and employs 12 people.

Gefen Biomed Investments Leadership Team

Limor Kohen, CEO
Efrat Romano, Director
BenZion Weiner, Director
Moshe Talbi, Executive
Gal Dikshtein, Director, MBA
Guy Rosen, Director
Uri BenOr, President, MBA
Roi Kalmar, Executive
Ahuva Brand, Director
Meir Rock, Director, Ph.D
David Grossman, Director
Samuel Baklache, Director
Hila Kiron, Director
Meni More, CEO
Yair Fudim, Director, MBA
Elad Nagar, Director
Anit Portman, CFO
Miri Sharir, Director, MBA
Tali Biron, Executive
Hezi Sidon, Director
Beny Sidon, President
Dan Zeskind, Director

Stock Performance Indicators

Did you try this?

Run Risk-Return Analysis Now

Risk-Return Analysis

View associations between returns expected from investment and the risk you assume
All  Next Launch Risk-Return Analysis

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Portfolio Quick Import module to import or update all your transactions via one easy-to-use interface.